| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 02/28/2013 | US20130052226 Compositions and methods for preventing or treating a human parvovirus infection |
| 02/28/2013 | US20130052225 Infectious dna vaccines against chikungunya virus |
| 02/28/2013 | US20130052224 Production of poliovirus at high titers for vaccine production |
| 02/28/2013 | US20130052223 Universal vaccine against h5n1 lineages |
| 02/28/2013 | US20130052221 Dna-protein vaccination protocols |
| 02/28/2013 | US20130052220 Yeast-hiv antigen compositions and methods of using the same |
| 02/28/2013 | US20130052218 Recombinant measles viruses expressing epitopes of antigens of rna viruses - use for the preparation of vaccine compositions |
| 02/28/2013 | US20130052216 Targeted heterologous antigen presentation on calicivirus virus-like particles |
| 02/28/2013 | US20130052208 Process for Preparing an Immunoglobulin Composition |
| 02/28/2013 | US20130052204 (poly)-glycerolphosphate-based anti-gram positive bacterial vaccine |
| 02/28/2013 | US20130052187 Antibodies Directed Against Hepatitis C Virus E1E2 Complex, Compositions of HCV Particles, and Pharmaceutical Compositions |
| 02/28/2013 | US20130052184 Gelatinase inhibitors and prodrugs |
| 02/28/2013 | US20130052182 Method of reducing biofilms |
| 02/28/2013 | US20130052179 Arginine deiminase mutant and preparation and application thereof |
| 02/28/2013 | US20130052172 Methods for diagnosing and treating cardiac defects |
| 02/28/2013 | US20130052164 Isolated nucleotide molecule and method of sensing and killing of pathogenic microorganism |
| 02/28/2013 | US20130052163 Human Rhinovirus (HRV) Antibodies |
| 02/28/2013 | US20130052162 Boosting immune defense by upregulating ccaat/enhancer binding protein epsilon |
| 02/28/2013 | US20130052161 Inhibitors of flaviviridae viruses |
| 02/28/2013 | US20130052159 Methods for treatment of microbial disorders |
| 02/28/2013 | US20130052156 Antiviral method |
| 02/28/2013 | US20130052154 Compositions and Methods for the Treatment of Lung Inflammation |
| 02/28/2013 | US20130052153 Method of preparing hydrogel structure |
| 02/28/2013 | US20130052145 Adhesive slow-release formulations for the local administration of curcumin |
| 02/28/2013 | US20130052135 Molecules With Extended Half-Lives, Compositions And Uses Thereof |
| 02/28/2013 | US20130052127 Composite body for antigen or drug delivery |
| 02/28/2013 | CA2846416A1 Tripartite bioactive composition providing anti-oxidant and anti-inflammatory effects with immune system and stem cell production enhancement |
| 02/28/2013 | CA2846348A1 Compositions and methods for treating viral diseases |
| 02/28/2013 | CA2846121A1 Hydrous adhesive skin patch |
| 02/28/2013 | CA2846092A1 Peg-interferon lambda 1 conjugates |
| 02/28/2013 | CA2845884A1 Clostridium difficile antibodies |
| 02/28/2013 | CA2845872A1 Herpes simplex virus nanoemulsion vaccine |
| 02/28/2013 | CA2845055A1 Method for producing dry extracts |
| 02/28/2013 | CA2844386A1 Crystal forms of a hcv protease inhibitor |
| 02/27/2013 | EP2561879A1 Macrophage activating factor for use in the treatment of chronic fatigue syndrome (CFS) and CFS-related diseases and disorders |
| 02/27/2013 | EP2561874A2 Pharmaceutical compositions for treating cancer |
| 02/27/2013 | EP2561861A1 Water-soluble pharmaceutical composition comprising at least one therapeutically active substance having hydrophobic properties and at least one compound selected from among sialoglycosphingolipids, glycosphingolipids or a mixture of sialoglycosphingolipids and glycosphingolipids |
| 02/27/2013 | EP2560977A1 New ag(i) compounds with chelating ligands and their use in pharmaceutical compositions |
| 02/27/2013 | EP2560976A1 Furopyridine compounds and uses thereof |
| 02/27/2013 | EP2560949A1 Tranylcypromine derivatives as inhibitors of histone demethylase lsd1 and/or lsd2 |
| 02/27/2013 | EP2560947A1 Lysine specific demethylase-1 inhibitors and their use |
| 02/27/2013 | EP2560691A2 Process for preparing an immunoglobulin composition |
| 02/27/2013 | EP2560688A1 Combination of drugs with protein-binding prodrugs |
| 02/27/2013 | EP2560682A2 Antibody preparations |
| 02/27/2013 | EP2560678A1 Pharmaceutical compositions |
| 02/27/2013 | EP2560677A1 Cold treatment |
| 02/27/2013 | EP2560669A1 Casein peptide for use in the treatment of uterine infections |
| 02/27/2013 | EP2560657A2 Anti-viral compounds |
| 02/27/2013 | EP2560656A2 Anti-viral compounds |
| 02/27/2013 | EP2560652A2 Anti-viral compounds |
| 02/27/2013 | EP2560636A2 Anti-viral compounds |
| 02/27/2013 | EP2560635A2 Anti-viral compounds |
| 02/27/2013 | EP2560628A2 Anti-viral compounds |
| 02/27/2013 | EP2143444A9 Compositions for inhibition of angiogenesis |
| 02/27/2013 | CN102947334A Antibodies for treatment of clostridium difficile-associated infection and disease |
| 02/27/2013 | CN102947307A Novel antifungal 5,6-dihydro-4-[(difluoroethyl)phenyl]-4h-pyrrolo[1,2-a][1,4]benzodiazepine and 4-(difluoroethyl)phenyl-6h-pyrrolo[1,2-a][1,4]benzodiazepine derivatives |
| 02/27/2013 | CN102947302A Triazolo [4, 5 - b] pyridin derivatives |
| 02/27/2013 | CN102947265A Lysine specific demethylase-1 inhibitors and their use |
| 02/27/2013 | CN102946888A Compositions containing purine and pyrimidine nucleosides, peptides, and manganese and their uses |
| 02/27/2013 | CN102946881A Anti-viral compounds |
| 02/27/2013 | CN102946876A Viral inhibitor compositions for in vivo therapeutic use comprising combination of (-) -carvone, geraniol and further essential oil component |
| 02/27/2013 | CN102946861A Concentrated protein formulations and uses thereof |
| 02/27/2013 | CN102943087A Novel subunit vaccine against rabbit hemorrhagic disease virus and preparation method thereof |
| 02/27/2013 | CN102942629A Humanized antibody for resisting severe fever with thrombocytopenia syndrome bunyavirus (SFTSV) |
| 02/27/2013 | CN102942624A Galectin-3 binding protein, preparation and application thereof |
| 02/27/2013 | CN102942617A Streptococcus suis quorum sensing system blocking peptide and application of streptococcus suis quorum sensing system blocking peptide |
| 02/27/2013 | CN102942605A Preparation method and application of Jasminum lanceolarium medium-ring iridoids |
| 02/27/2013 | CN102942590A Alpha-(adamantane)amino phosphonic acid, its preparation method and application |
| 02/27/2013 | CN102942577A Cefoxitin sodium compound-containing pharmaceutical composition |
| 02/27/2013 | CN102942576A New crystal form composition of cefminox sodium and preparation method thereof |
| 02/27/2013 | CN102942567A Disodium salt crystal of pyrroloquinoline quinone |
| 02/27/2013 | CN102942563A Polymorphic and other crystalline forms of cis-ftc |
| 02/27/2013 | CN102942545A Nepetalactone-o-bromobenzoic acid ester as well as preparation process and use of nepetalactone-o-bromobenzoic acid ester |
| 02/27/2013 | CN102942544A Nepetalactone trifluoromethyl benzoate as well as preparation process and use of nepetalactone trifluoromethyl benzoate |
| 02/27/2013 | CN102941688A Method for manufacturing health care toilet paper |
| 02/27/2013 | CN102940886A Biological barrier penetrating agent and preparation method thereof |
| 02/27/2013 | CN102940875A Paa protein, antibody prepared from the same, and application thereof |
| 02/27/2013 | CN102940874A Application of small molecular polypeptide CW14 in preparation of goat antibacterial medicament |
| 02/27/2013 | CN102940859A Preparation method of traditional Chinese medicine particles for treating cold and influenza |
| 02/27/2013 | CN102940856A Method for preparing anti-viral oral liquid and product thereof |
| 02/27/2013 | CN102940831A External use effervescent tablet for inhibiting bacteria and curing gynecologic inflammations |
| 02/27/2013 | CN102940828A Traditional Chinese medicine for treating pulmonary tuberculosis |
| 02/27/2013 | CN102940815A Medicine prescription for treating tuberculosis and tuberculous rheumatism |
| 02/27/2013 | CN102940811A Traditional Chinese medicine for treating flat wart |
| 02/27/2013 | CN102940774A Traditional Chinese medicine for preventing porcine reproductive and respiratory syndrome (PRRS) |
| 02/27/2013 | CN102940760A Traditional Chinese medicine composition for preventing and treating swine fever |
| 02/27/2013 | CN102940735A Traditional Chinese medicine (TCM) for treating postpartum wind and colds of pregnant women |
| 02/27/2013 | CN102940725A Traditional Chinese medicine composition for treating viral cold |
| 02/27/2013 | CN102940724A Preparation method of traditional Chinese medicine compound capsule for diminishing inflammation |
| 02/27/2013 | CN102940722A Chinese medicinal composition for treating bacterial diseases of animals and preparation method thereof |
| 02/27/2013 | CN102940717A Chinese medicament for treating cattle foot-and-mouth diseases |
| 02/27/2013 | CN102940712A Application of immature bitter orange in preparation of anti-prion medicament |
| 02/27/2013 | CN102940708A Traditional Chinese medicine chewable tablet for treating upper respiratory tract infection and preparation method of chewable tablet |
| 02/27/2013 | CN102940698A Medicine for treating dermatophytosis |
| 02/27/2013 | CN102940689A Chinese herbal medicine oral liquid for treating chicken chronic respiratory diseases |
| 02/27/2013 | CN102940686A Application of szechwan chinaberry fruit extract in preparation of antiviral drug and extraction method thereof |
| 02/27/2013 | CN102940684A Traditional Chinese medicine composition containing illicium henryi and preparation method thereof |
| 02/27/2013 | CN102940661A Medicine for treating parotitis |
| 02/27/2013 | CN102940660A Chinese herbal medicine for treating tetanus |
| 02/27/2013 | CN102940652A Eubacterium biforme preparation and use thereof |